Premium
A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis
Author(s) -
Shah Rikin K.,
Munson Mary,
Wierenga Klaas J.,
Pokala Hanumantha R.,
Newburger Peter E.,
Crawford David
Publication year - 2017
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26571
Subject(s) - medicine , neutropenia , congenital neutropenia , myelofibrosis , filgrastim , hematopoietic stem cell transplantation , haematopoiesis , diamond–blackfan anemia , bone marrow failure , mutation , phenotype , transplantation , missense mutation , immunology , bone marrow , stem cell , gene , genetics , chemotherapy , biology , rna , ribosome
VPS45 ‐associated severe congenital neutropenia (SCN) is a rare disorder characterized by life‐threating infections, neutropenia, neutrophil and platelet dysfunction, poor response to filgrastim, and myelofibrosis with extramedullary hematopoiesis. We present a patient with SCN due to a homozygous c.1403C>T (p.P468L) mutation in VPS45 , critical regulator of SNARE‐dependent membrane fusion. Structural modeling indicates that P468, like the T224 and E238 residues affected by previously reported mutations, cluster in a VPS45 “hinge” region, indicating its critical role in membrane fusion and VPS45 ‐associated SCN. Bone marrow transplantation, complicated by early graft failure rescued with stem cell boost, led to resolution of the hematopoietic phenotype.